Capstan Therapeutics
Priya Karmali, Ph.D., is Capstan’s Chief Technology Officer. With over 20 years of experience in the field of lipid nanoparticle mediated nucleic acid delivery from discovery to development, Priya has led drug product development efforts for multiple RNA therapeutics. Priya previously served as Vice President of Technology Innovation and Development at Arcturus Therapeutics and held positions of increasing seniority at Regulus Therapeutics and Nitto.
This person is not in any offices
Capstan Therapeutics
2 followers
Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.